Clinical trial
A Phase II Study of Doxycycline in Patients With Amyloidosis
NCT01677286 is registered in ClinicalTrials.gov with Boston University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Doxycycline in Patients With Amyloidosis
- Lead sponsor
- Boston University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- December 15, 2015
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.